Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ratner

Showing results (31-40 of 4,048) with videos related to

Pageof 405
Sort By:
Nature Biotechnology|March 10, 2015
Roche spends $1 billion on Foundation Medicine's tumor profilingMark Ratner
Nature|January 15, 1976
Evidence that mutations in the suA polarity suppressing gene directly affect termination factor rhoD Ratner
Journal of the American Medical Directors Association|July 15, 2003
Dollars and sense: revenue opportunities in home care medicineEdward Ratner
Journal of the National Cancer Institute|April 4, 1990
Lymphocytes stimulated with recombinant human interleukin-2: relationship between motility into protein matrix and in vivo localization in normal and neoplastic tissues of miceS Ratner
Business and Health|November 5, 1990
Rewarding healthy behaviorD Ratner
New Jersey Medicine : the Journal of the Medical Society of New Jersey|May 17, 2000
A talk with Irving Ratner, MD. 207th president of MSNJ. Interview by Leah Z. ZiskinI Ratner
Urology|May 30, 2001
Current controversies that adversely affect interstitial cystitis patientsV Ratner
Nature Biotechnology|April 9, 2005
Syrrx acquisition signals maturation of structure-based discoveryMark Ratner
Nature Biotechnology|October 8, 2005
Profile: Jean DeleageMark Ratner
Nature Biotechnology|September 10, 2014
Small biotech steers HDAC inhibitor to clinicMark Ratner
Pageof 405

Showing results (31-40 of 4,048) with videos related to

Sort By:
Pageof 405
Nature Biotechnology|March 10, 2015
Roche spends $1 billion on Foundation Medicine's tumor profilingMark Ratner
Nature|January 15, 1976
Evidence that mutations in the suA polarity suppressing gene directly affect termination factor rhoD Ratner
Journal of the American Medical Directors Association|July 15, 2003
Dollars and sense: revenue opportunities in home care medicineEdward Ratner
Journal of the National Cancer Institute|April 4, 1990
Lymphocytes stimulated with recombinant human interleukin-2: relationship between motility into protein matrix and in vivo localization in normal and neoplastic tissues of miceS Ratner
Business and Health|November 5, 1990
Rewarding healthy behaviorD Ratner
New Jersey Medicine : the Journal of the Medical Society of New Jersey|May 17, 2000
A talk with Irving Ratner, MD. 207th president of MSNJ. Interview by Leah Z. ZiskinI Ratner
Urology|May 30, 2001
Current controversies that adversely affect interstitial cystitis patientsV Ratner
Nature Biotechnology|April 9, 2005
Syrrx acquisition signals maturation of structure-based discoveryMark Ratner
Nature Biotechnology|October 8, 2005
Profile: Jean DeleageMark Ratner
Nature Biotechnology|September 10, 2014
Small biotech steers HDAC inhibitor to clinicMark Ratner
Pageof 405